A Randomized, Double-Blind, Placebo-Controlled Clinical Trial on the Effect of a Dietary Supplement Containing Dry Artichoke and Bergamot Extracts on Metabolic and Vascular Risk Factors in Individuals with Suboptimal Cholesterol Levels

A Randomized, Double-Blind, Placebo-Controlled Clinical Trial on the Effect of a Dietary Supplement Containing Dry Artichoke and Bergamot Extracts on Metabolic and Vascular Risk Factors in Individuals with Suboptimal Cholesterol Levels

Key Findings

The study found that a dietary supplement containing dry extracts of bergamot and artichoke significantly improved serum lipid concentration and insulin sensitivity, reduced high-sensitivity C-reactive protein (hs-CRP), and positively impacted non-alcoholic fatty liver disease (NAFLD) in individuals with suboptimal cholesterol levels.

Practical Solutions and Value

These findings support the use of the tested dietary supplement as a safe and effective approach for the prevention and management of a broad spectrum of cardiometabolic disorders.

Application in Clinical Practice

Clinical trials are essential for developing safe and effective treatments. Our AI-driven platform, DocSym, consolidates ICD-11 standards, clinical protocols, and research into a single, easily accessible knowledge base for clinicians, helping to extend the benefits of clinical trials into everyday medical practice.

Streamlining Operations and Patient Care

In today’s healthcare environment, streamlining operations is crucial. Our mobile apps support scheduling, monitoring treatments, and telemedicine, making it easier to manage patient care and expand services digitally, ultimately enhancing workflows and improving patient outcomes.

Embracing Digital Solutions

By utilizing AI, clinics can enhance their workflows, reduce paper routines, and improve patient outcomes. Learn more about how we can help at aidevmd.com.